Product Information
KETOROLAC 10 MG TABLET is a generic product labeled by Leading Pharma, LLC, priced at $0.1645 per EA under NDC 69315026001. Its NADAC has been published 118 times since Jul 3, 2024.
FDA first approved this application on Feb 23, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Leading Pharma, LLCNDC
69315026001
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
KETOROLAC TROMETHAMINEApproval Type
Generic (ANDA)
FDA Application
ANDA215745FDA Approved
2/23/2023
TE Code
AB
On Market Since
3/1/2024
Pharmacological Classes
Price Statistics
The NADAC for KETOROLAC 10 MG TABLET has been published 118 times since Jul 3, 2024, and over the history we have for it it has declined 61.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1645 per EA |
|---|---|
| All-time high | $0.4224 (Jul 10, 2024) |
| All-time low | $0.1244 (Mar 18, 2026) |
| 52-week high | $0.2502 |
| 52-week low | $0.1244 |
| Median price | $0.2534 |
| Average price | $0.2441 |
| Largest weekly change | -31.6% (Nov 20, 2024) |
| Weeks tracked | 118 |
| Tracking since | Jul 3, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the KETOROLAC TROMETHAMINE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Leading Pharma, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
KETOROLAC TROMETHAMINE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Cyclooxygenase Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of KETOROLAC 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for KETOROLAC 10 MG TABLET, manufactured by Leading Pharma, LLC, is $0.1645 per EA (NDC 69315026001), effective Sep 30, 2026.
How has the price of KETOROLAC 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for KETOROLAC 10 MG TABLET has declined 61.1%. It has been tracked across 118 weekly CMS publications since Jul 3, 2024.
What are the highest and lowest recorded NADAC prices for KETOROLAC 10 MG TABLET?
Since Jul 3, 2024, the NADAC for KETOROLAC 10 MG TABLET has ranged from a low of $0.1244 (Mar 18, 2026) to a high of $0.4224 (Jul 10, 2024), with a median of $0.2534 per EA.
Are there cheaper alternatives to KETOROLAC 10 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of KETOROLAC 10 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures KETOROLAC 10 MG TABLET?
KETOROLAC 10 MG TABLET (NDC 69315026001) is labeled by Leading Pharma, LLC, and CMS classifies it as a generic product.